Unscheduled vaginal bleeding in Levonorgestrel implant users. Unscheduled vaginal bleeding, Spotting, Implant, Levonorgestrel, Prophylaxis, Contraception
Conditions
Interventions
Healthy female patients undergoing Levonorgestrel implant were randomized to receive oral contraceptive pills (OCP) and take OCP for 90 days after contraceptive implant was done. Patients assigned to
Experimental Drug,Placebo Comparator Drug
Study group,Study group
Sponsors
Endowment fund, Faculty of Medicine, Chiang Mai University
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. Reproductive age women that was Levonorgestrel implant user. 2. Aged 18 -40 years 3. No underlying disease or contraindication for hormonal contraceptive methods 4. Can read and write in Thai
Exclusion criteria
Exclusion criteria: 1. Breast feeding women or postpartum in 6 months 2. The women that have been use implant contraception before 3. Abnormal vaginal bleeding before use contraceptive implant 4. Allergic to folic acid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of bleeding days after implantation 90 days after implantation Ratio scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Amount of bleeding episodes after implantation 90 days after implantation Ratio scale,Average of bleeding days per episode 90 days after implantation Ratio scale,Side effect of hormonal drugs 90 days after implantation Ordinal scale,Satisfaction survey 90 days after implantation Ordinal scale | — |
Countries
Thailand
Contacts
Public ContactChalongraj Ratanawongsaroj
Faculty of Medicine, Chiang Mai University
Outcome results
None listed